Anti-infective Agents : Penicillins
IAMOC1 “Amoclav injection”
Each vial contains amoxicillin sodium 500 gm, clavulanic acid 100 mg; 0.6gm/vial
ICURA1 “Curam injection”
Each vial contains amoxicillin sodium 1000 mg, clavulanate potassium 200 mg; 1.2gm/vial
OAUGM5 “Augmentin syrup”
Each 5 ml contains amoxicillin trihydrate 400 mg, clavulanate potassium 57 mg; 35 ml/bot
OCURA1 “Curam tablet”
Each tab contains amoxicillin 500 mg, clavulanic acid 125 mg
OCURA2 “Curam suspension”
312.5mg/5ml; 60ml/bot
OAUGM4 “Augmentin FC tablet”
Each tab contains amoxicillin trihydrate 875 mg, clavulanate potassium 125 mg
OCURA4 “Curam FC tablet”
Each tab contains amoxicillin trihydrate 875 mg, clavulanic acid 125 mg
適應症：葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌，及其他具有感受性細菌引起之感染症。
Usual dose:
Bacterial infection: PO
Mild to moderate: 500 mg q12h or 250 mg q8h.
Severe: 875 mg q12h or 500 mg q8h.
Bacterial infection: IV
Adult: 1.2 g q8h for 48 h (followed by oral therapy).
Pediatric (2-14 yrs): 30 mg/kg/ q6h.
Dose adjustment:
Renal failure: CrCl 10-30 ml/min, q12h; CrCl <10 ml/min, q24h.
Adverse effect:
Common: rash, urticaria, diarrhea, nausea, vomiting.
Serious: hepatotoxicity.
健保使用規範：用於1.急性化膿性中耳炎或急性化膿性鼻竇炎；2.急性下呼吸道感染；3.厭氧性細菌感染；4.菌血症等適應症。得免附細菌敏感試驗報告，惟以十日為限。